LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Metastatic Non-small Cell Lung Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Emek Medical Center, Afula, Israel
Contact: Study coordinator (Gil Bar Sela) · gil_ba@clalit.org.il · 972-50-2061207
Bnai zion MC, Haifa, Israel
Contact: Study coordinator (Abed Agbarya) · abed.agbarya@b-zion.org.il · 972-48-359359
Central Alabama Research, Birmingham, Alabama, United States
Contact: Study coordinator (Lorie Szymela) · lszymela@centralalabamaresearch.com · 205-949-1907
Western Regional Medical Center, LLC, Goodyear, Arizona, United States
Contact: Study coordinator (Janiece Denaro) · Janiece.Denaro@ctca-hope.com · 1- 623-207-3196
St. Jude Herritage Medical Group, Fullerton, California, United States
Contact: Study coordinator (Larissa Ulloa) · larissa.lacson@providence.org · 800-627-8106
Hoag Family Cancer Institute - Hoag Memorial Hospital, Newport Beach, California, United States
Contact: Study coordinator (Patrice Jones) · Patrice.Jones@hoag.org · 949-764-5501
Sutter Institute for Medical Research, Sacramento, California, United States
Contact: Study coordinator (Clara Dunn) · Clara.Dunn@sutterhealth.org · 1-916-454-6931
Florida Cancer Affiliates - Ocala Oncology, Ocala, Florida, United States
Contact: Study coordinator (Megan Cerrato) · Megan.Cerrato@usoncology.com · 352-547-1943
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Maya Douglas) · maya.douglas@moffitt.org · 813-745-0969
Northwest Oncology & Hematology, Barrington, Illinois, United States
Contact: Study coordinator (Khalada Admad) · khalada.ahmad@ascension.org · 224-273-8971
Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst, Illinois, United States
Contact: Study coordinator (Jessica Schnase) · Jessica.Schnase@EEHealth.org · 630-646-6029
Edward Cancer Center, Naperville, Illinois, United States
Contact: Study coordinator (Jessica Schnase) · Jessica.Schnase@EEHealth.org · 630-646-6029
Cancer Treatment Centers of America (CTCA), Zion, Illinois, United States
Contact: Study coordinator (Sylvia Schneiderman) · sylvia.schneiderman@coh.org · 1-847-746-6983
Parkview Packnett Family Cancer Institute, Fort Wayne, Indiana, United States
Contact: Study coordinator (Brian Chang, Dr.) · brian2.chang@parkview.com · 1-833-724-8326
Contact: Principal Investigator (Brian Chang)
Franciscan Health Indianapolis, Indianapolis, Indiana, United States
Contact: Study coordinator (Olivia Martin) · Olivia.martin@franciscanalliance.org · 317-528-7822
University of Kansas Cancer Center, Westwood, Kansas, United States
Contact: Study coordinator (KUCC Navigation) · kucc_navigation@kumc.edu · 913-588-3671
Luminis Health Radiation Oncology - Anne Arundel Health System, Annapolis, Missouri, United States
Contact: Study coordinator (Rachael Niedelman) · rniedelman@velocityclinical.com · 443 659 8685
University of Kansas Cancer Center - North, Kansas City, Missouri, United States
Contact: Study coordinator (KUCC Navigation) · kucc_navigation@kumc.edu · 913-588-3671
University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States
Contact: Study coordinator (KUCC Navigation) · kucc_navigation@kumc.edu · 913-588-3671
University of Kansas Cancer Center - Overland Park, Overland, Missouri, United States
Contact: Study coordinator (KUCC Navigation) · kucc_navigation@kumc.edu · 913-588-3671
New York Cancer & Blood Specialists (NYCBS), New Hyde Park, New York, United States
Contact: Study coordinator (Laura Parisi) · lparisi@nycancer.com · 631-675-5146
New York Cancer & Blood Specialists (NYCBS), New York, New York, United States
Contact: Study coordinator (Laura Parisi) · lparisi@nycancer.com · 631-675-5146
University of Rochester Medical Center, Rochester, New York, United States
Contact: Study coordinator (Sierra Napoli) · Sierra_Napoli@URMC.Rochester.edu · 585-276-0648
New York Cancer & Blood Specialists (NYCBS), Shirley, New York, United States
Contact: Study coordinator (Laura Parisi) · lparisi@nycancer.com · 631-675-5146
New York Cancer & Blood Specialists (NYCBS), The Bronx, New York, United States
Contact: Study coordinator (Laura Parisi) · lparisi@nycancer.com · 631-675-5146
WakeMed Health & Hospitals, Cary, North Carolina, United States
Contact: Study coordinator (Taylor Childress) · tchildress@wakemed.org · 919-350-1700
Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Ryan Roddy) · ryan.roddy@pennmedicine.upenn.edu · 267-408-3199
AHN Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Ariel Lopez-Chavez) · clinicaltrials@ahn.org · 412-518-5025
Old Parkland Hospital Hematology Oncology Clinic, Dallas, Texas, United States
Contact: Study coordinator (Ebele Mbanugo) · ebele.mbanugo@utsouthwestern.edu · 214-645-0326
UT Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Ebele Mbanugo) · ebele.mbanugo@utsouthwestern.edu · 214-645-0326
DHR Health Oncology Institute, Edinburg, Texas, United States
Contact: Study coordinator (Edgar Lopez) · ed.lopez@dhr-rgv.com · 956-362-2394
Houston Methodist Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Nicole Barrios) · nkbarrios@houstonmethodist.org · 713-441-5607
Contact: Principal Investigator (Jun Zhang)
Methodist Richardson Cancer Center, Richardson, Texas, United States
Contact: Study coordinator (Crystee Cooper) · ClinicalResearch@mhd.com · 214-947-1280
Jason Bates at University of Texas Health Science Center, San Antonio, Texas, United States
Contact: Study coordinator (Epp Goodwin) · goodwine@uthscsa.edu · 210-450-5798
MultiCare Regional Cancer Center, Auburn, Washington, United States
Contact: Study coordinator (Stacey Macon) · Stacey.macon@multicare.org · 1-253-403-0791
MultiCare Regional Cancer Center, Gig Harbor, Washington, United States
Contact: Study coordinator (Stacey Macon) · Stacey.macon@multicare.org · 1-253-403-0791
MultiCare Regional Cancer Center, Puyallup, Washington, United States
Contact: Study coordinator (Stacey Macon) · Stacey.macon@multicare.org · 1-253-403-0791
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown, Spokane, Washington, United States
Contact: Study coordinator (Rachel Smith) · rachel.smith@multicare.org · 1-509-838-2531
MultiCare Institute for Research & Innovation, Tacoma, Washington, United States
Contact: Study coordinator (Stacey Macon) · Stacey.macon@multicare.org · 1-253-403-0791
Universitaetsklinik fuer Innere Medizin V Innsbruck, Innsbruck, Austria
Contact: Study coordinator (Florian Kocher) · florian.kocher@i-med.ac.at · +43512504-0
University Hospital Salzburg, Salzburg, Austria
Contact: Study coordinator (Richard Greil) · r.greil@salk.at · 43-662-4482 4100
Karl Landsteiner Institut fur Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf, Vienna, Austria
Contact: Study coordinator (Maximilian Hochmair) · maximilian.hochmair@gesundheitsverbund.at · +43 1 27700 3855
Cliniques universitaires Saint-Luc, Brussels, Belgium
Contact: Study coordinator (Rachel Galot) · rachel.galot@uclouvain.be · 32-2-764 1037
AZ Maria Middelares - Campus Maria Middelares, Ghent, Belgium
Contact: Study coordinator (Paul Germonpre) · Paul.germonpre@mijnziekenhuis.be · +3292468400
Fakultni nemocnice Olomouc FNOL, Olomouc, Czechia
Contact: Study coordinator (Bohuslav Melichar) · bohuslav.melichar@fnol.cz · +420588444295
Nemocnice Agel Ostrava-Vitkovice / Agel Ostrava-Vitkovice Hospital, Ostrava, Czechia
Contact: Study coordinator (Jaromir Roubec) · jaromir.roubec@vtn.agel.cz · +420595633400
General University Hospital in Prague, Prague, Czechia
Contact: Study coordinator (Milada Zemanova) · milada.zemanova@vfn.cz · +420224966405
Centre Hospitalier Intercommunal de Creteil, Créteil, France
Contact: Study coordinator (Christos Chouaid) · christos.chouaid@chicreteil.fr · +33 1 57 02 20 70
CHU Limoges, Limoges, France
Contact: Study coordinator (Thomas Egenod) · Thomas.Egenod@chu-limoges.fr · +33 5 55 05 68 92
Contact: Principal Investigator (Thomas Egenod)
Hopital Europeen, Marseille, France
Contact: Study coordinator (Remi Bonetto) · drc-he@hopital-europeen.fr · +33 4 13 42 74 82
Hopital Prive du Confluent, Nantes, France
Contact: Study coordinator (Cyriac Blonz) · BLONZ.CYRIAC@groupeconfluent.fr · +33 2 28 27 20 88
Contact: Principal Investigator (Cyriac Blonz)
Institut Curie, Paris, France
Contact: Study coordinator (Nicolas Girard) · nicolas.girard2@curie.fr · 33144324677
CHU de Bordeaux, Pessac, France
Contact: Study coordinator (Claire Bardel) · claire.bardel@chu-bordeaux.fr · +33 5 57 65 63 38
Centre Hospitalier Lyon Sud, Pierre-Bénite, France
Contact: Study coordinator (Sebastien Couraud) · sebastien.couraud@chu-lyon.fr · +33 (0)4 78 86 44 01
Nouvel Hopital Civil (NHC), Strasbourg, France
Contact: Study coordinator (Celine Mascaux) · celine.mascaux@chru-strasbourg.fr · 33-3-69 55 06 44
Evangelische Lungenklinik Berlin, Berlin, Germany
Contact: Study coordinator (Norman von-Palubitzki) · Norman.von-Palubitzki@jsd.de · +49 30 9480 2569
University Hospital Giessen, ZIM IV, Giessen, Germany
Contact: Study coordinator (Anika Holzapfel) · Anika.Holzapfel@uniklinikum-giessen.de · +49 641 985 59263
Krankenhaus Martha-Maria Halle-Dolau, Halle, Germany
Contact: Study coordinator (Franziska Gebauer) · franziska.gebauer@martha-maria.de · +49 345 559 1434
Contact: Principal Investigator (Wolfgang Schuette)
Thoraxklinik Heidelberg, Heidelberg, Germany
Contact: Study coordinator (Helge Bischoff) · Studienkoordination-Onkologie.THOR@med.uni-heidelberg.de · +49 6221 396 1350
Klinik Loewenstein gGmbH, Löwenstein, Germany
Contact: Study coordinator (Nicolyn Roessel) · Nicolyn.Roessel@slk-kliniken.de · +49 7130 15 6226
Pius-Hospital Oldenburg, Oldenburg, Germany
Contact: Study coordinator (Frank Griesinger) · Frank.Griesinger@Pius-Hospital.de · +49 441 229 1611
Farkasgyepui Tudogyogyintezet, Farkasgyepű, Hungary
Contact: Study coordinator (Zsolt Kiraly) · dr.kiraly.zsolt@gmail.com · +36 20 926 4476
Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét, Hungary
Contact: Study coordinator (Zsuzsanna Kelemen) · study.zsuzsannadrkelemen@gmail.com · +36 20 588 1072
Tolna Varmegyei Balassa Janos Korhaz, Szekszárd, Hungary
Contact: Study coordinator (Yousuf Al-Farhat) · yalfarhat@gmail.com · +36 30 644 1744
A.O. SS. Antonio e Biagio e Cesare Arrigo di Alessandria, Alessandria, Italy
Contact: Study coordinator (Pier Luigi Piovano) · plpiovano@ospedale.al.it · 00390131208345
Contact: Study coordinator (Clinical Trial Center) · clinicaltrialcenter@ospedale.al.it · +39 013120 6893
Humanitas Gavazzeni, Bergamo, Italy
Contact: Study coordinator (Chiara Catania) · chiara.catania@gavazzeni.it · 00390354204106
Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant'Anna, Ferrara, Italy
Contact: Study coordinator (Luana Calabro) · luana.calabro@unife.it · 00390532239661
IRCCS - Istituto Romagnolo per lo Studio Dei Tumori, Dino Amadori, Meldola, Italy
Contact: Study coordinator (Angelo Delmonte) · angelo.delmonte@irst.emr.it · +39 0543 739100
Azienda Sanitaria Territoriale Pesaro Urbino, Pesaro, Italy
Contact: Study coordinator (Rita Chiari) · rita.chiari@sanita.marche.it · +39 331 689 3387
Universita Campus Bio-Medico di Roma (UCBM) - Policlinico Universitario, Roma, Italy
Contact: Study coordinator (Giuseppe Tonini) · g.tonini@policlinicocampus.it · +39 06 225411000
Ospedale Isola Tiberina Gemelli, Rome, Italy
Contact: Study coordinator (Emilio Bria) · emilio.bria@policlinicogemelli.it · +39 06 6837 0271
Azienda Ospedaliera Universitaria Senese Policlinico Le Scotte, Siena, Italy
Contact: Study coordinator (Michele Maio) · maio@unisi.it · 00390577586336
Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
Contact: Study coordinator (Saitama Medical University International Medical Center) · chikenme@saitama-med.ac.jp · 042-984-4183
Rijnstate Ziekenhuis, Arnhem, Netherlands
Contact: Study coordinator (Siyar Demir) · sdemir@rijnstate.nl · +31 88 005 6730
Medisch Centrum Leeuwarden (MCL) - Oncologisch Centrum Leeuwarden (OCL), Friesland, Netherlands
Contact: Study coordinator (Johanna Hellinga) · Johanna.Post@mcl.nl · 0031 58 286 3768
St. Jansdal ziekenhuis, Harderwijk, Netherlands
Contact: Study coordinator (Martine Lammens) · m.lammens@mediflowresearch.nl · +31 341 463 911
St Antonius Ziekenhuis, Utrecht, Netherlands
Contact: Study coordinator (Lisanne Kastelijn) · l.kastelijn1@antoniusziekenhuis.nl · 31-88-3201572
Uniwersytecki Szpital Kliniczny, Poznan, Poland
Contact: Study coordinator (Rodryg Ramlau) · rodryg.ramlau@usk.poznan.pl · 00 48 61 854 90 40
NCCS Singapore, Singapore, Singapore
Study coordinator · clinical.trials@nccs.com.sg · +65 6436 8000
Curie Oncology, Singapore, Singapore
Contact: Study coordinator (Toh Chee Keong) · info@curieresearch.sg · +65 6259 5538
Icon Cancer Centre Singapore (Singapore Oncology Consultants), Singapore, Singapore
Contact: Study coordinator (Daniel Chan) · daniel.chan@icon.team · 6604 9919
Hospital Universitario del Vinalopo, Elche, Alicante, Spain
Contact: Study coordinator (Eugenio Palomares Garcia) · epalomares@vinaloposalud.com · +34 966679800
Hospital Universitario Virgen del Rocio, Seville, Andalusia, Spain
Contact: Study coordinator (Carlos Cabrera) · ccabrera@uomi.es · +34 932 287 445
Clinica Mi Tres Torres Barcelona - Giromed Institute, Barcelona, Catalonia, Spain
Contact: Study coordinator (Carlos Cabrera Galvez) · ccabrera@uomi.es · +34 932 287 445
Hospital Universitario de Torrejon, Torrejón de Ardoz, Madrid, Spain
Contact: Study coordinator (Luis Cabezon Gutierrez) · lcabezon@torrejonsalud.com · +34 916262626
Institut Catala d'Oncologia, Barcelona, Spain
Contact: Study coordinator (Enric Carcereny Costa) · ecarcereny@iconcologia.net · +34 677 254 583
Hospital Universitario Arnau de Vilanova, Lleida, Spain
Contact: Study coordinator (Alberto Rodrigo Caceres) · alberto.rcaceres@gmail.com · +34 973 003 754
Clinica Universidad de Navarra (Madrid), Madrid, Spain
Contact: Study coordinator (Miguel Fernandez de Sanmamed Gutierrez) · msanmamed@unav.es · +34 948255400
Hospital Ruber Internacional, Madrid, Spain
Contact: Study coordinator (Antonio Calles Blanco) · antonio.calles.co@quironsalud.es · +34 913875090
Hospital Regional Universitario de Malaga, Málaga, Spain
Contact: Study coordinator (Airam Padilla Alvarez) · airampadillaalvarez@gmail.com · +34 951 308 130
Clinica Universidad de Navarra, Pamplona, Spain
Contact: Study coordinator (Miguel Fernandez de Sanmamed Gutierrez) · msanmamed@unav.es · +34 948255400
Cantonal Hospital Baden, Baden, Switzerland
Contact: Study coordinator (Sacha Rothschild) · klinische_forschung.onkologie@ksb.ch · +41 56 486 27 62
HFR Freiburg-Kantonsspital, Fribourg, Switzerland
Contact: Study coordinator (Alessandra Curioni-Fontecedro) · Alessandra.curioni-fontecedro@h-fr.ch · +41 26 306 20 10
Contact: Principal Investigator (Alessandra Curioni-Fontecedro)
Charing Cross Hospital, London, Greater London, United Kingdom
Contact: Study coordinator (Denebeth Calla) · Denebeth.calla@nhs.net · 020-331-10291
Contact: Principal Investigator (Waleed Mohammed)
University Hospitals of Leicester NHS Trust, Leicester, Leicestershire, United Kingdom
Contact: Study coordinator (Clare Belcher) · clare.belcher2@nhs.net · 01162586935
Contact: Principal Investigator (Sean Dulloo)
The Royal Marsden NHS Foundation Trust, London, London, United Kingdom
Contact: Study coordinator (Michael Davidson) · lung.trials@rmh.nhs.uk · +44 20 7352 8171
Clatterbridge Cancer Centre - Liverpool, Liverpool, Merseyside, United Kingdom
Contact: Study coordinator (William McCaig) · william.mccaig1@nhs.net · 07795 129946
Contact: Principal Investigator (Carles Escriu)
The Royal Marsden NHS Foundation Trust - Sutton, Sutton, Sutton, United Kingdom
Contact: Study coordinator (Michael Davidson) · lung.trials@rmh.nhs.uk · +44 20 7352 8171

צפייה במקור ב־ClinicalTrials.gov

ניסויים דומים

ניסויים נוספים שמגייסים כעת ועשויים להיות רלוונטיים לפי מצב רפואי, טיפול, שלב או מיקום

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)

ישראלמגייס משתתפיםPHASE3

Jerusalem, Israel · Petah Tikva, Israel

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Stereotactic Radiotherapy (SBRT) of Lung Metastasis

Non-small Cell Lung Cancer · Metastasis From Other Cancers

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

Toronto, Canada

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Adenocarcinoma of Lung · Lung Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

Phoenix, United States · Brainerd, United States